ZFIN ChEBI: milbemycin

Relationships

is a type of: avermectin analogue macrolide spiroketal

avermectin analogue macrolide spiroketal Show first 5 Terms
has subtype: (1R,4S,4'S,5'S,6R,6'S,8R,10E,13R,14E,16Z,20R,21R,24S)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione (1S,4R,4'S,5'S,6'S,7R,8R,9S,10E,12E,14R,16E,19R,21R)-4',8,9-trihydroxy-10-(hydroxymethyl)-7-methoxy-5',6,14,16-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[2,20-dioxatricyclo[17.3.1.04,9]tricosa-5,10,12,16-tetraene-21,2'-oxane]-3-one (1S,5'R,6'R,10Z,12Z,14S,15S,16Z,19R,21S)-6'-[(2S)-butan-2-yl]-7,15-dihydroxy-5',6,10,14,16-pentamethylspiro[2,20-dioxatricyclo[17.3.1.04,9]tricosa-4(9),5,7,10,12,16-hexaene-21,2'-oxane]-3,4'-dione 4,25-diethyl-4,25-demethyl-milbemycin beta3 5-Oxoavermectin "2a" aglycone ... Show All 81 Terms

(1R,4S,4'S,5'S,6R,6'S,8R,10E,13R,14E,16Z,20R,21R,24S)-4',21,24-trihydroxy-5',11,13,22-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2,18-dione (1S,4R,4'S,5'S,6'S,7R,8R,9S,10E,12E,14R,16E,19R,21R)-4',8,9-trihydroxy-10-(hydroxymethyl)-7-methoxy-5',6,14,16-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[2,20-dioxatricyclo[17.3.1.04,9]tricosa-5,10,12,16-tetraene-21,2'-oxane]-3-one (1S,5'R,6'R,10Z,12Z,14S,15S,16Z,19R,21S)-6'-[(2S)-butan-2-yl]-7,15-dihydroxy-5',6,10,14,16-pentamethylspiro[2,20-dioxatricyclo[17.3.1.04,9]tricosa-4(9),5,7,10,12,16-hexaene-21,2'-oxane]-3,4'-dione 4,25-diethyl-4,25-demethyl-milbemycin beta3 5-Oxoavermectin "2a" aglycone 5-Oxoavermectin "2b" aglycone 5-Oxoavermectin ''2a'' aglycone 6,8a-Seco-6,8a-deoxy-2,5-didehydroaverme 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone 6,8a-Seco-6,8a-deoxy-5-oxoavermectin''2b''aglycone 27-formaldehyde-milbemycin beta14 [(3'R,4S,5'R,6S,6'S,8R,10E,13S,14E,16E,20R,21R,24S)-6'-[(E)-but-2-en-2-yl]-3',21,24-trihydroxy-5',11,13,22-tetramethyl-12-(2-methylpropanoyloxy)-2-oxospiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-4'-yl] 2-methylpropanoate [(4S,5'S,6R,6'S,8R,10E,13S,14E,16E,20R,21R,24S)-6'-[(E)-but-2-en-2-yl]-21,24-dihydroxy-5',11,13,22-tetramethyl-2-oxospiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-12-yl] 2-methylpropanoate Delta-2-Ivermectin B1a Doramectin congener 1 Doramectin congener 3 epi-Ivermectin B1a Ivermectin B1 aglycone Ivermectin monosaccharide LL-F28249 beta LL-F28249alpha LL-F28249gamma LSM-1593 LSM-1662 LSM-5397 milbemycin A3 Milbemycin A3 oxime milbemycin A4 Milbemycin A4 oxime Milbemycin alpha20 Milbemycin alpha21 Milbemycin alpha22 Milbemycin alpha23 Milbemycin alpha24 Milbemycin alpha25 Milbemycin alpha26 Milbemycin alpha27 Milbemycin alpha28 Milbemycin alpha29 Milbemycin alpha30 Milbemycin beta3 Milbemycin beta9 Milbemycin beta10 Milbemycin beta11 Milbemycin beta12 Milbemycin beta13 Milbemycin beta14 milbemycin D Milbemycin J Milbemycin K Milbemycin oxime Moxidectin Nemadectin Selamectin Tenvermectin C Tenvermectin D UK-78,624 UK-78614 UK-78618 UK-78621 UK-78629 UK-78630 UK-79465 VM 44857 VM 44864 VM 44865 VM 44866 VM-44857 VM-44864 VM-44865 VM-44866 VM44867 VM44868 VM47704 VM48130 VM48633 VM48640 VM48641 VM48642 VM54168 VM54339 Show first 5 Terms
has_role: bacterial metabolite

bacterial metabolite Show first 5 Terms

Phenotype

Phenotype resulting from milbemycin

Phenotype where environments contain milbemycin

Phenotype modified by environments containing milbemycin

Human Disease / Model Data

Citations